All In Biotech

Free tool

FAERS Monitor: Jadenu

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 206910 or its brand name (Jadenu, Deferasirox). Reports on generic versions are filed under their own applications.

Reports

6,732

Serious

4,874

72% of reports

Hospitalization

2,507

Death reported

1,125

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death696
  • sickle cell anaemia with crisis563
  • diarrhoea478
  • off label use419
  • nausea335
  • haemoglobin decreased312
  • pyrexia310
  • drug ineffective286
  • fatigue272
  • vomiting250
  • anaemia216
  • abdominal pain210
  • serum ferritin increased208
  • pneumonia196
  • product dose omission issue194

Reports by year received

View as table
YearReports
20062
20073
200814
200916
201031
201137
201273
201344
201444
2015213
2016518
2017585
2018599
2019658
2020750
2021675
2022757
2023536
2024496
2025368
2026313

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,427 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
serum ferritin increasedSignal208128.2111.825,104
sickle cell anaemia with crisisSignal563115.7106.761,675
haemoglobin decreasedSignal3129.58.52,375
anaemiaSignal2163.53.1395
abdominal painSignal2102.82.5248
pyrexiaSignal3102.82.5363
deathSignal6962.52.4666
diarrhoeaSignal4782.32.1367
product dose omission issueSignal1942.11.8106
pneumonia1961.91.683
vomiting2501.71.567
off label use4191.51.471
nausea3351.31.227
fatigue2721.11.02
drug ineffective2860.70.646

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.